Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells

Journal of Virology

Volumn 83, Issue 10, 2009, Pages 4766-4777

  Krishna, Venkatramana D ^a,b   Rangappa, Manjuladevi ^a   Satchidanandam, Vijaya ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b Bhat Biotech India (P) Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT FACTOR H; NONSTRUCTURAL PROTEIN 1; VIRUS PROTEIN; NS1 PROTEIN, FLAVIVIRUS; VIRUS ANTIBODY;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL STRAIN BHK; CELL SURFACE; CONVALESCENCE; EMBRYO; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPRECIPITATION; JAPANESE ENCEPHALITIS VIRUS; LYSIS; MOUSE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; TARGET CELL; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS RECOMBINANT; WEST NILE FLAVIVIRUS; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; EPIDEMIC ENCEPHALITIS; IMMUNOLOGY; METABOLISM; VIROLOGY;

DENGUE VIRUS; JAPANESE ENCEPHALITIS VIRUS; POXVIRIDAE; WEST NILE VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; COMPLEMENT FACTOR H; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; MICE; MICE, INBRED BALB C; VIRAL NONSTRUCTURAL PROTEINS;

EID: 65349159136     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01850-08     Document Type: Article

References (56)

1. Alcon, S., A. Talarmin, M. Debruyne, A. Falconar, V. Deubel, and M. Flamand. 2002. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40:376-381. (Pubitemid 34130856)
2. Alcon-LePoder, S., M. T. Drouet, P. Roux, M. P. Frenkiel, M. Arborio, A. M. Durand-Schneider, M. Maurice, I. Le Blanc, J. Gruenberg, and M. Flamand. 2005. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J. Virol. 79:11403-11411.
3. Avirutnan, P., N. Punyadee, S. Noisakran, C. Komoltri, S. Thiemmeca, K. Auethavornanan, A. Jairungsri, R. Kanlaya, N. Tangthawornchaikul, C. Puttikhunt, S. N. Pattanakitsakul, P. T. Yenchitsomanus, J. Mongkolsapaya, W. Kasinrerk, N. Sittisombut, M. Husmann, M. Blettner, S. Vasanawathana, S. Bhakdi, and P. Malasit. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193:1078-1088.
4. Avirutnan, P., L. Zhang, N. Punyadee, A. Manuyakorn, C. Puttikhunt, W. Kasinrerk, P. Malasit, J. P. Atkinson, and M. S. Diamond. 2007. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 3:e183. (Pubitemid 350291614)
5. Barilla-LaBarca, M. L., M. K. Liszewski, J. D. Lambris, D. Hourcade, and J. P. Atkinson. 2002. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J. Immunol. 168:6298-6304. (Pubitemid 34620051)
6. Bokisch, V. A., F. H. Top, Jr., P. K. Russell, F. J. Dixon, and H. J. Muller- Eberhard. 1973. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N. Engl. J. Med. 289:996-1000.
7. Burke, D. S., A. Nisalak, M. A. Ussery, T. Laorakpongse, and S. Chantavibul. 1985. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J. Infect. Dis. 151:1093-1099. (Pubitemid 15065982)
8. Cardiff, R. D., and J. K. Lund. 1976. Distribution of dengue-2 antigens by electron immunocytochemistry. Infect. Immun. 13:1699-1709.
9. Cardiff, R. D., T. G. McCloud, W. E. Brandt, and P. K. Russell. 1970. Molecular size and charge relationships of the soluble complement-fixing antigens of dengue viruses. Virology 41:569-572.
10. Chang, H. H., H. F. Shyu, Y. M. Wang, D. S. Sun, R. H. Shyu, S. S. Tang, and Y. S. Huang. 2002. Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J. Infect. Dis. 186:743-751.
11. Chung, K. M., M. K. Liszewski, G. Nybakken, A. E. Davis, R. R. Townsend, D. H. Fremont, J. P. Atkinson, and M. S. Diamond. 2006. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl. Acad. Sci. USA 103:19111-19116.
12. Chung, K. M., G. E. Nybakken, B. S. Thompson, M. J. Engle, A. Marri, D. H. Fremont, and M. S. Diamond. 2006. Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80:1340-1351. (Pubitemid 43134091)
13. Chung, K. M., B. S. Thompson, D. H. Fremont, and M. S. Diamond. 2007. Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor- mediated phagocytosis and clearance of West Nile virus-infected cells. J. Virol. 81:9551-9555. (Pubitemid 47311499)
14. Despres, P., J. Dietrich, M. Girard, and M. Bouloy. 1991. Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice. J. Gen. Virol. 72:2811-2816.
15. Falconar, A. K. 1997. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142:897-916.
16. Falgout, B., M. Bray, J. J. Schlesinger, and C. J. Lai. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64:4356-4363. (Pubitemid 20279846)
17. Falgout, B., R. Chanock, and C. J. Lai. 1989. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J. Virol. 63:1852-1860. (Pubitemid 19107777)
18. Fan, W. F., and P. W. Mason. 1990. Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA. Virology 177:470-476.
19. Flamand, M., F. Megret, M. Mathieu, J. Lepault, F. A. Rey, and V. Deubel. 1999. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73:6104-6110. (Pubitemid 29274901)
20. Garcia, G., D. W. Vaughn, and R. M. Del Angel. 1997. Recognition of synthetic oligopeptides from nonstructural proteins NS1 and NS3 of dengue- 4 virus by sera from dengue virus-infected children. Am. J. Trop. Med. Hyg. 56:466-470. (Pubitemid 27188438)
21. Gorter, A., and S. Meri. 1999. Immune evasion of tumor cells using membrane- bound complement regulatory proteins. Immunol. Today 20:576-582.
22. Gould, E. A., A. Buckley, A. D. Barrett, and N. Cammack. 1986. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J. Gen. Virol. 67:591-595. (Pubitemid 16158597)
23. Gould, E. A., A. Buckley, N. Cammack, A. D. Barrett, J. C. Clegg, R. Ishak, and M. G. Varma. 1985. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J. Gen. Virol. 66:1369-1382. (Pubitemid 15070379)
24. Henchal, E. A., L. S. Henchal, and J. J. Schlesinger. 1988. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol. 69:2101-2107. (Pubitemid 18186638)
25. Jacobs, M. G., P. J. Robinson, C. Bletchly, J. M. Mackenzie, and P. R. Young. 2000. Dengue virus nonstructural protein 1 is expressed in a glycosylphosphatidylinositol- linked form that is capable of signal transduction. FASEB J. 14:1603-1610. (Pubitemid 30639071)
26. Jacobs, S. C., J. R. Stephenson, and G. W. Wilkinson. 1992. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J. Virol. 66:2086-2095.
27. Jacobs, S. C., J. R. Stephenson, and G. W. Wilkinson. 1994. Protection elicited by a replication-defective adenovirus vector expressing the tickborne encephalitis virus non-structural glycoprotein NS1. J. Gen. Virol. 75:2399-2402. (Pubitemid 24282255)
28. Kaufman, B. M., P. L. Summers, D. R. Dubois, W. H. Cohen, M. K. Gentry, R. L. Timchak, D. S. Burke, and K. H. Eckels. 1989. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 41:576-580. (Pubitemid 20000630)
29. Kimura-Kuroda, J., and K. Yasui. 1988. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 141:3606-3610. (Pubitemid 18275547)
30. Kumar, P., V. D. Krishna, P. Sulochana, G. Nirmala, M. Haridattatreya, and V. Satchidanandam. 2004. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J. Gen. Virol. 85:471-482.
31. Libraty, D. H., P. R. Young, D. Pickering, T. P. Endy, S. Kalayanarooj, S. Green, D. W. Vaughn, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186:1165-1168. (Pubitemid 35177121)
32. Lin, C. F., S. C. Chiu, Y. L. Hsiao, S. W. Wan, H. Y. Lei, A. L. Shiau, H. S. Liu, T. M. Yeh, S. H. Chen, C. C. Liu, and Y. S. Lin. 2005. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J. Immunol. 174:395-403.
33. Lin, C. F., H. Y. Lei, A. L. Shiau, C. C. Liu, H. S. Liu, T. M. Yeh, S. H. Chen, and Y. S. Lin. 2003. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J. Med. Virol. 69:82-90. (Pubitemid 35403658)
34. Lin, C. F., H. Y. Lei, A. L. Shiau, H. S. Liu, T. M. Yeh, S. H. Chen, C. C. Liu, S. C. Chiu, and Y. S. Lin. 2002. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J. Immunol. 169:657-664. (Pubitemid 34753420)
35. Lin, Y. L., L. K. Chen, C. L. Liao, C. T. Yeh, S. H. Ma, J. L. Chen, Y. L. Huang, S. S. Chen, and H. Y. Chiang. 1998. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 72:191-200. (Pubitemid 28048828)
36. Macdonald, J., J. Tonry, R. A. Hall, B. Williams, G. Palacios, M. S. Ashok, O. Jabado, D. Clark, R. B. Tesh, T. Briese, and W. I. Lipkin. 2005. NS1 protein secretion during the acute phase of West Nile virus infection. J. Virol. 79:13924-13933. (Pubitemid 41552691)
37. Mason, P. W., S. Pincus, M. J. Fournier, T. L. Mason, R. E. Shope, and E. Paoletti. 1991. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180:294-305.
38. Matveeva, V. A., R. V. Popova, E. A. Kvetkova, L. O. Chernicina, V. I. Zlobin, N. M. Puchovskaya, and O. V. Morozova. 1995. Antibodies against tickborne encephalitis virus (TBEV) non-structural and structural proteins in human sera and spinal fluid. Immunol. Lett. 46:1-4.
39. Mehlhop, E., K. Whitby, T. Oliphant, A. Marri, M. Engle, and M. S. Diamond. 2005. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79:7466-7477. (Pubitemid 40756783)
40. Mellado-Sanchez, G., J. Garcia-Cordero, R. Luria-Perez, L. Lazaro-Olan, L. Santos-Argumedo, B. Gutierrez-Castaneda, I. Estrada-Garcia, and L. Cedillo-Barron. 2005. DNA priming E and NS1 constructs - homologous proteins boosting immunization strategy to improve immune response against dengue in mice. Viral Immunol. 18:709-721. (Pubitemid 43038535)
41. Murali-Krishna, K., B. Ramireddy, V. Ravi, and R. Manjunath. 1995. Recognition of nonstructural protein peptides by cytotoxic T lymphocytes raised against Japanese encephalitis virus. Microbiol. Immunol. 39:1021-1024. (Pubitemid 26007111)
42. Noisakran, S., T. Dechtawewat, P. Rinkaewkan, C. Puttikhunt, A. Kanjanahaluethai, W. Kasinrerk, N. Sittisombut, and P. Malasit. 2007. Characterization of dengue virus NS1 stably expressed in 293T cell lines. J. Virol. Methods 142:67-80. (Pubitemid 46590405)
43. Oglesby, T. J., C. J. Allen, M. K. Liszewski, D. J. White, and J. P. Atkinson. 1992. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J. Exp. Med. 175:1547-1551.
44. Pryor, M. J., and P. J. Wright. 1993. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology 194:769-780.
45. Schlesinger, J. J., M. W. Brandriss, C. B. Cropp, and T. P. Monath. 1986. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J. Virol. 60:1153-1155. (Pubitemid 17179296)
46. Schlesinger, J. J., M. W. Brandriss, J. R. Putnak, and E. E. Walsh. 1990. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. J. Gen. Virol. 71:593-599.
47. Schlesinger, J. J., M. W. Brandriss, and E. E. Walsh. 1985. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol. 135:2805-2809. (Pubitemid 16217156)
48. Schlesinger, J. J., M. Foltzer, and S. Chapman. 1993. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192:132-141.
49. Smith, T. J., W. E. Brandt, J. L. Swanson, J. M. McCown, and E. L. Buescher. 1970. Physical and biological properties of dengue-2 virus and associated antigens. J. Virol. 5:524-532.
50. Westaway, E. G., and M. R. Goodman. 1987. Variation in distribution of the three flavivirus-specified glycoproteins detected by immunofluorescence in infected Vero cells. Arch. Virol. 94:215-228. (Pubitemid 17064121)
51. Winkler, G., S. E. Maxwell, C. Ruemmler, and V. Stollar. 1989. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171:302-305.
52. Winkler, G., V. B. Randolph, G. R. Cleaves, T. E. Ryan, and V. Stollar. 1988. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology 162:187-196.
53. Wright, P. J., M. R. Cauchi, and M. L. Ng. 1989. Definition of the carboxy termini of the three glycoproteins specified by dengue virus type 2. Virology 171:61-67.
54. Young, P. R., P. A. Hilditch, C. Bletchly, and W. Halloran. 2000. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 38:1053-1057. (Pubitemid 30140558)
55. Zhang, M. J., M. J. Wang, S. Z. Jiang, and W. Y. Ma. 1989. Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J. Med. Virol. 29:133-138.
56. Zhao, J., S. A. Rollins, S. E. Maher, A. L. Bothwell, and P. J. Sims. 1991. Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement. J. Biol. Chem. 266:13418-13422. (Pubitemid 21907361)